{
  "id": "meld_combined",
  "title": "Model for End-Stage Liver Disease (Combined MELD)",
  "description": "Offers multiple versions of MELD for liver transplant planning and end-stage liver disease severity assessment",
  "category": "gastroenterology",
  "version": "Combined 2023",
  "parameters": [
    {
      "name": "meld_version",
      "type": "string",
      "required": true,
      "description": "MELD version to calculate",
      "options": ["original", "meld_na", "meld_3_0"],
      "validation": {
        "enum": ["original", "meld_na", "meld_3_0"]
      }
    },
    {
      "name": "bilirubin",
      "type": "float",
      "required": true,
      "description": "Serum bilirubin in mg/dL",
      "validation": {
        "min": 0.1,
        "max": 50.0
      },
      "unit": "mg/dL"
    },
    {
      "name": "creatinine",
      "type": "float",
      "required": true,
      "description": "Serum creatinine in mg/dL",
      "validation": {
        "min": 0.1,
        "max": 15.0
      },
      "unit": "mg/dL"
    },
    {
      "name": "inr",
      "type": "float",
      "required": true,
      "description": "International Normalized Ratio (INR) for prothrombin time",
      "validation": {
        "min": 0.8,
        "max": 10.0
      }
    },
    {
      "name": "sodium",
      "type": "float",
      "required": false,
      "description": "Serum sodium in mEq/L (required for MELD-Na and MELD 3.0)",
      "validation": {
        "min": 120,
        "max": 160
      },
      "unit": "mEq/L"
    },
    {
      "name": "albumin",
      "type": "float",
      "required": false,
      "description": "Serum albumin in g/dL (required for MELD 3.0)",
      "validation": {
        "min": 1.0,
        "max": 6.0
      },
      "unit": "g/dL"
    },
    {
      "name": "age",
      "type": "integer",
      "required": false,
      "description": "Patient age in years (required for MELD 3.0)",
      "validation": {
        "min": 12,
        "max": 120
      },
      "unit": "years"
    },
    {
      "name": "sex",
      "type": "string",
      "required": false,
      "description": "Patient sex (required for MELD 3.0)",
      "options": ["male", "female"],
      "validation": {
        "enum": ["male", "female"]
      }
    },
    {
      "name": "dialysis_twice_in_week",
      "type": "string",
      "required": false,
      "description": "Patient received dialysis at least twice in the past week",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    }
  ],
  "result": {
    "name": "meld_score",
    "type": "integer",
    "unit": "points",
    "description": "MELD score indicating severity of liver disease and transplant priority"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 6,
        "max": 9,
        "stage": "Mild Disease",
        "description": "Lower mortality risk",
        "interpretation": "Mild liver disease with low 90-day mortality risk (<2%). Generally not considered for liver transplantation unless specific indications present."
      },
      {
        "min": 10,
        "max": 14,
        "stage": "Moderate Disease",
        "description": "Moderate mortality risk",
        "interpretation": "Moderate liver disease with intermediate mortality risk (6-20%). May be considered for liver transplantation evaluation depending on clinical circumstances."
      },
      {
        "min": 15,
        "max": 19,
        "stage": "Severe Disease",
        "description": "High mortality risk",
        "interpretation": "Severe liver disease with high mortality risk (>20%). Strong indication for liver transplantation evaluation. MELD ≥15 is generally the threshold for transplant consideration."
      },
      {
        "min": 20,
        "max": 29,
        "stage": "Very Severe Disease",
        "description": "Very high mortality risk",
        "interpretation": "Very severe liver disease with very high mortality risk (>50%). High priority for liver transplantation. Close monitoring and intensive management required."
      },
      {
        "min": 30,
        "max": 40,
        "stage": "Critical Disease",
        "description": "Extremely high mortality risk",
        "interpretation": "Critical liver disease with extremely high mortality risk (>80%). Highest priority for liver transplantation. Consider intensive care management and urgent transplant evaluation."
      }
    ]
  },
  "references": [
    "Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.",
    "Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003 Jan;124(1):91-6. doi: 10.1053/gast.2003.50016.",
    "Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.",
    "Kwong AJ, Ebel NH, Kim WR, Lake JR, Smith JM, Schladt DP, et al. OPTN/SRTR 2021 Annual Data Report: Liver. Am J Transplant. 2023 Feb;23(2 Suppl 1):S178-S263. doi: 10.1016/j.ajt.2023.02.006.",
    "Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, et al. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology. 2021 Dec;161(6):1887-1895.e4. doi: 10.1053/j.gastro.2021.08.050."
  ],
  "formula": "Version-specific formulas: Original MELD = 3.78×ln(bilirubin) + 11.2×ln(INR) + 9.57×ln(creatinine) + 6.43; MELD-Na incorporates sodium; MELD 3.0 includes albumin, age, and sex adjustments",
  "notes": [
    "MELD 3.0 is the current standard for organ transplantation (effective 2023)",
    "Use most recent lab values within 48 hours",
    "Maximum creatinine of 4.0 mg/dL used in calculations if higher",
    "Minimum values: bilirubin 1.0 mg/dL, creatinine 1.0 mg/dL, INR 1.0",
    "Sodium clamped between 125-137 mEq/L for MELD-Na calculations",
    "Patients under 12 years should use PELD (Pediatric End-Stage Liver Disease) score",
    "OPTN accepts maximum submitted score of 40",
    "Score should be recalculated as lab values change",
    "Different formulas apply for ages 12-18 vs ≥18 years in MELD 3.0"
  ]
}